Search Results 8231-8240 of 42529 for oral

  1. Diaphragm Pacing System (DPS) in Participants with Amyotrophic Lateral Sclerosis (ALS) - Mayo Clinic

    Women of child bearing potential must use an adequate form of contraception: abstinence, hormonal contraception (oral contraception, implanted contraception ...

  2. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

  3. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery ... Oral and thr...oat cancer, Head and neck cancer, Mouth cancer, Thyroid ...

  4. Head and neck cancers - Doctors and departments - Mayo Clinic

    ... Oral and throat cancer, Head and neck cancer, Skin cancer, Thyroid nodule, Thyroid cancer, Skin lesion, Laryngeal cancer, Salivary gland cancer, Salivary ...

  5. Zoster Eye Disease Study - Mayo Clinic

    Ability to take oral medication, and are willing to adhere to study medication regimen. Age 18 years or older. Diagnosed with HZO in one eye based on both ...

  6. A Study Of The Effect Of Ixazomib On The Reservoir Of T Cells Infected With HIV DNA - Mayo Clinic

    ... oral absorption or tolerance of ixazomib including difficulty swallowing; Participation in other clinical trials, including those with other investigational ...

  7. A Study to Evaluate KD025 in Subjects with Diffuse Cutaneous Systemic Sclerosis - Mayo Clinic

    on stable doses of hormonal contraception for at least 3 months (e.g., oral, injectable, implant, transdermal) plus one barrier method; or; 2 barrier methods ...

  8. A Phase 2, Multicenter, Randomized Study of AP26113 - Mayo Clinic

    Have malabsorption syndrome or other GI illness that could affect oral absorption of the study drug. Have any condition or illness that, in the opinion of ...

  9. Study Of A Triple Combination Therapy, DTRM-555, In Patients With R/R CLL Or R/R Non-Hodgkin's Lymphomas - Mayo Clinic

    However, single drug therapies have limitations, therefore, the current study is evaluating a novel oral combination of targeted drugs as a way of overcoming ...

  10. A Study to Evaluate the Safety and Effectiveness of Upadacitinib (ABT-494) in Subjects with Moderately to Severely Active Crohn's Disease - Mayo Clinic

    Subject on oral aminosalicylates who: has not been on stable doses of these medications for at least 14 days prior to Baseline; or; has discontinued these ...